TB

Next-Generation Sequencing for Tuberculosis Detection: Insights from Findx Scientist

Tonight, I watched a recording on the ONT YouTube channel. Swapna Uplekar, a Principal Scientist in Genomics and Sequencing at Findx presented the session, “Targeted next-generation sequencing for drug-resistant tuberculosis detection.”Uplekar works at Findx to use next-generation sequencing to develop diagnostics for diseases globally. Tuberculosis, Uplekar emphasized, remains the top killer, worsened by COVID-19. Drug-resistant cases often remain […]
Read more

Oxford Nanopore TB-DR Tuberculosis Drug Resistance Testing

Seanne P. Buckwalter from the Mayo Clinic spoke about “Rapid analysis of drug resistant M. tuberculosis complex” at London Calling 2024. The Mayo Clinic has numerous locations, and the three main ones, Buckwalter noted, are in the US. Buckwalter supports the mycobacteriology/mycology laboratory with fifty-six employees, nine BSL3 rooms, and over 48,000 mycobacterial cultures performed […]
Read more

Targeted Sequencing of Mycobacterium tuberculosis Resistance Genes with Nanopore

“Profiling drug-resistant Mycobacterium tuberculosis with targeted nanopore sequencing” was the title of the sessionn Shannon Murphy from the Wadsworth Center – New York State Department of Health presented at the Nanopore Community Meeting 2022. Murphy spoke about how they are planning on using Nanopore sequencing to address some of the challenges of Mycobacterium tuberculosis (MTB). […]
Read more
Press ESC key to close search